Medicare Enrolled

Dr. Roopa Sathyaprakash, MD

Endocrinology · Colleyville, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
7141 COLLEYVILLE BLVD, Colleyville, TX 76034
8177933422
In practice since 2007 (19 years)
NPI: 1588706519 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sathyaprakash from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sathyaprakash? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sathyaprakash

Dr. Roopa Sathyaprakash is an endocrinology in Colleyville, TX, with 19 years in practice. Based on federal Medicare data, Dr. Sathyaprakash performed 1,530 Medicare services across 932 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sathyaprakash received a total of $14,776 from 64 pharmaceutical and/or device companies across 915 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sathyaprakash is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 28% volume in TX$ $14,776 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,530
Medicare services
Top 28% in TX for endocrinology
932
Unique beneficiaries
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~81 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)444$88$235
Blood glucose (sugar) test performed by hand-held instrument326$3$19
Office visit, established patient (20-29 min)240$57$158
Hemoglobin A1c test (diabetes monitoring)166$10$66
Lipid panel (cholesterol and triglycerides)160$13$77
Ultrasound scan of head and neck soft tissue146$73$270
New patient office visit (45-59 min)48$119$358
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$14,776
Total received (2018-2024)
Avg $2,111/year across 7 years
Top 26% in TX for endocrinology
64
Companies
915
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,776 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,509
2023
$1,887
2022
$1,973
2021
$2,240
2020
$1,893
2019
$2,046
2018
$2,227

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$2,359
AstraZeneca Pharmaceuticals LP
$1,611
Novo Nordisk Inc
$1,581
SANOFI-AVENTIS U.S. LLC
$1,031
Boehringer Ingelheim Pharmaceuticals, Inc.
$877
Abbott Laboratories
$782
Amgen Inc.
$576
Mannkind Corporation
$370
Insulet Corporation
$347
Merck Sharp & Dohme Corporation
$330
Antares Pharma, Inc.
$315
IBSA Pharma Inc.
$298
Amarin Pharma Inc.
$290
Amneal Pharmaceuticals LLC
$274
MannKind Corporation
$269
Janssen Pharmaceuticals, Inc
$254
Dexcom, Inc.
$207
Alexion Pharmaceuticals, Inc.
$197
AbbVie, Inc.
$191
CeQur Corporation
$158
Medtronic, Inc.
$142
Kowa Pharmaceuticals America, Inc.
$142
Bayer Healthcare Pharmaceuticals Inc.
$132
Shire North American Group Inc
$108
Xeris Pharmaceuticals, Inc.
$107
Becton, Dickinson and Company
$102
Corcept Therapeutics
$96
Radius Health, Inc.
$83
LifeScan, Inc.
$82
Currax Pharmaceuticals LLC
$79
Medtronic MiniMed, Inc.
$78
Acella Pharmaceuticals, LLC
$77
BETA BIONICS, INC.
$75
Ultragenyx Pharmaceutical Inc.
$73
DEXCOM, INC.
$73
Horizon Therapeutics plc
$70
Nevro Corp.
$69
Eisai Inc.
$58
VistaPharm, Inc.
$55
Tandem Diabetes Care, Inc.
$52
PFIZER INC.
$52
Bayer HealthCare Pharmaceuticals Inc.
$47
VIVUS LLC
$46
Supernus Pharmaceuticals, Inc.
$43
Takeda Pharmaceuticals U.S.A., Inc.
$40
Tolmar, Inc.
$37
Clarus Therapeutics Inc.
$37
Ascendis Pharma Inc
$36
Neurocrine Biosciences, Inc.
$34
Merck Sharp & Dohme LLC
$34
Zealand Pharma US, Inc.
$29
Astellas Pharma US Inc
$29
Companion Medical, Inc.
$29
Acerus Pharmaceuticals Corporation
$26
Kyowa Kirin, Inc.
$26
VIVUS, Inc.
$24
RECORDATI_RARE_DISEASES_INC.
$21
AbbVie Inc.
$20
Alvogen Inc
$18
Intuity Medical Inc
$18
Amryt Pharma Holdings Ltd
$17
Amphastar Pharmaceuticals, Inc.
$17
Avvisto Therapeutics, LLC
$15
ARBOR PHARMACEUTICALS, INC.
$11
Top 3 companies account for 37.6% of total payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · Belviq · CONTRAVE · CYCLOSET · CeQur Simplicity · Crysvita · DEXCOM G6 TRANSMITTER · DIABETES - DISEASE · Dexcom G6 Transmitter · EVENITY · Edarbi · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMALOG · HUMULIN · HUMULIN U · INPEN SMART INSULIN DELIVERY SYSTEM · INTELLIS ADAPTIVESTIM · INVOKANA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LICART · LYUMJEV · Licart · Livalo · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · Minimed 770G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NOCDURNA · NP Thyroid 60 · Natesto · OT Verio Flex Starter Kit · OTREXUP · Omnipod · OneTouch · Ozempic · PRALUENT · PREVNAR 20 · Pogo Automatic Blood Glucose Monitoring System · Prolia · QSYMIA · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLATRO · STEGLUJAN · STRENSIQ · SYNTHROID · Saxenda · Senza · Synthroid · TEPEZZA · TERIPARATIDE · TOUJEO · TRULICITY · TZIELD · Thyquidity · Tirosint · Tresiba · Tymlos · UNITHROID · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XYOSTED · ZEGALOGUE · ZEPBOUND · iLet Bionic Pancreas · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $966 per 100 Medicare services performed
Looking for a endocrinology in Colleyville?
Compare endocrinologys in the Colleyville area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
108
Per 100K population
5.1
County median income
$81,905
Nearest hospital
SAINT CAMILLUS MEDICAL CENTER
2.9 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Sathyaprakash is a clinical cardiology specialist, with above-average Medicare volume (top 28% in TX), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Sathyaprakash experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Sathyaprakash performed 444 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sathyaprakash receive payments from pharmaceutical companies?
Yes. Dr. Sathyaprakash received a total of $14,776 from 64 companies across 915 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sathyaprakash's costs compare to other endocrinologys in Colleyville?
Dr. Sathyaprakash's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sathyaprakash) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →